01 adoption of Bipolar Electrode Laparoscopy by Surgeons Bipolar electrode laparoscopy systems are increasingly being favored by surgeons due to their superior precision and reduced tissue damage. Unlike traditional monopolar electrodes, bipolar systems use two electrodes to deliver electrical energy, minimizing the risk of burning surrounding tissues and offering better control over coagulation. This advancement is particularly valuable in delicate surgeries, where precision is crucial.For example, in January 2023, Cook Medical launched a new portfolio of bipolar electrodes tailored to meet the specific needs of urologists, providing more targeted and efficient treatments.The growing preference for bipolar electrode laparoscopy is accelerating the market's expansion, offering enhanced safety and better outcomes for patients, thereby solidifying its role in modern surgical procedures.
02 emergence of Multifunctional Laparoscopy System Comprising Electrodes The development of multifunctional laparoscopic systems is a key trend in the market, as these systems consolidate various surgical functions into one instrument. By integrating electrodes with other essential functions, such as vessel sealing, cutting, and grasping, these systems improve surgical efficiency and reduce the number of tools needed during procedures. Medtronic, for instance, offers the LigaSure retractable L-hook laparoscopic sealer-divider, which combines five key functions, including monopolar dissection, vessel sealing, atraumatic grasping, cold cutting, and blunt dissection. This multifunctionality streamlines the surgery process, enhancing both safety and precision. The growing demand for such instruments is driving market growth as healthcare providers seek to optimize surgery while minimizing operational complexity and time.
May 2026 Olympus Corporation signed an exclusive global distribution agreement with EndoRobotics Co., Ltd. to commercialize robot-assisted endoscopic technologies as part of its EndoTherapy portfolio. The collaboration expands Olympus' minimally invasive surgery ecosystem, complementing its portfolio of laparoscopic and electrosurgical instruments.
May 2026 Medtronic signed a Memorandum of Understanding (MoU) with Asan Medical Center to advance robotic surgery through joint clinical research, surgeon education, and technology development for the Hugo™ robotic-assisted surgery system. The collaboration supports the broader adoption of advanced laparoscopic surgical technologies, including compatible electrosurgical instruments.
October 2025 Olympus Corporation launched THUNDERBEAT™ II, its next-generation hybrid energy device for laparoscopic and open surgery. The device combines advanced bipolar and ultrasonic energy technologies to improve vessel sealing, hemostatic cutting, and surgical efficiency in minimally invasive procedures.